Myeloid Sarcoma: Symptoms, Diagnosis, Treatment and AML Connection
Updated: 2 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer: What is myeloid sarcoma?
Myeloid sarcoma is a tumor of abnormal immature white blood cells that develops outside the bone marrow, making it both a cancerous tumor and a blood cancer. It often occurs alongside AML, affecting about 1 in 4 people with AML. Only a biopsy confirms it, and treatment may include chemotherapy, radiation, targeted therapy and stem cell transplant. [1]
What the research says
In a large US registry analysis, fewer than half of people with myeloid sarcoma were alive at three and five years, and most deaths occurred in the first year. Among 573 cases diagnosed from 2000 to 2016, relative survival was 43.4% at three years and 39.0% at five years. About 51.1% received chemotherapy, 26.2% radiation therapy and 13.6% surgical management; chemotherapy and surgical management were associated with better survival. The leading cause of death was malignant disease, particularly leukemias (Mali et al., Medicine, 2025). [2]
A systematic review found that the tumor’s genetic profile often differs from the bone marrow’s, and that isolated relapse outside the marrow is common after transplant. The review pooled 85 studies and 7,241 patients; skin and soft tissue were the most common locations (31%). Among 112 patients with paired sequencing, 56% had discordant mutation profiles between the tumor and bone marrow. Among relapsed patients after transplant, 46% had an isolated extramedullary relapse. Venetoclax with hypomethylating agents achieved a 44% response rate, mainly in secondary disease, and the pooled median overall survival was 12.8 months (Padmanabhan et al., Cancers, 2025). [3]
Where can myeloid sarcoma develop?
Myeloid sarcoma can develop throughout the body. It forms outside the bone marrow, where related abnormal blood cells are normally found. [1]
Commonly described locations include lymph nodes, tissue under the skin and the gastrointestinal tract. [1]
Less common sites include the reproductive system, brain and lungs. The tumor’s location can shape the symptoms. For example, a tumor pressing on an organ may cause pain, while a tumor affecting the brain may cause neurological problems. [1]
How is myeloid sarcoma related to AML?
Myeloid sarcoma and AML involve the same type of cancer cell. AML is a blood cancer, while myeloid sarcoma forms a tumor outside the bone marrow. [1]
About 1 in 4 people with AML develop myeloid sarcoma. A person can also develop myeloid sarcoma without having AML. When it occurs without AML, it is called primary myeloid sarcoma. [1]
Because of this close relationship, healthcare professionals often use the same medications to treat myeloid sarcoma and AML. A bone marrow biopsy may be used to check whether AML is present alongside the tumor. [1]
What causes myeloid sarcoma?
Myeloid sarcoma develops when myeloid cells, which normally mature into healthy blood cells, become cancer cells. A genetic mutation can cause these cells to remain immature and become myeloblasts. The myeloblasts multiply and form a tumor that can damage nearby tissue. [1]
Researchers are not sure what causes the genetic change. They also do not know why myeloid sarcoma forms outside the bone marrow while related blood cancers do not usually form solid tumors. [1]
Who is at risk?
Having AML or another blood cancer increases the risk of myeloid sarcoma. Associated conditions include AML that is in remission, chronic myeloid leukemia, myeloproliferative neoplasms and myelodysplastic syndrome. [1]
These conditions are risk contexts, not proof that a tumor is myeloid sarcoma. Only a healthcare professional can interpret symptoms, imaging and tissue findings together.
Risk context | Why it matters |
AML | Myeloid sarcoma often occurs alongside AML, and the diseases involve the same cancer cell. |
AML in remission | Myeloid sarcoma can develop even when AML is in remission. |
CML | This blood cancer is associated with increased risk. |
Myeloproliferative neoplasms | These disorders are another associated risk context. |
Myelodysplastic syndrome | This bone-marrow disorder is also associated with myeloid sarcoma. |
What are the symptoms of myeloid sarcoma?
Myeloid sarcoma symptoms depend partly on where the tumor forms and may include fatigue, unexplained weight loss, loss of appetite, pain and soft lumps in the lymph nodes or skin. Possible symptoms include:
Fatigue.
Losing weight without trying.
Loss of appetite.
Pain where the tumor presses on an organ.
Soft lumps in the lymph nodes or skin.
These symptoms have many possible causes and do not confirm cancer. A soft lump, unexplained weight loss, persistent fatigue or new organ-related pain should be evaluated by a healthcare professional.
What complications can occur?
Without treatment, myeloid sarcoma may lead to AML in a person who does not already have it. Other potential complications depend on the tumor’s location. [1]
Complication | How it can occur |
Fractures | If disease spreads to the bones. |
Organ damage | If tumors develop in the intestines, kidneys or lungs. |
Neurological problems | If disease affects the brain. |
AML | The condition may cause AML when it is not already present. |
Prompt evaluation is important because early treatment may slow how quickly the disease spreads.
How is myeloid sarcoma diagnosed?
Diagnosis often begins by considering and ruling out other conditions that can cause tumors, including benign tumors or abscesses. Imaging helps locate the tumor and assess the wider situation, but imaging alone cannot confirm myeloid sarcoma. [1]
A biopsy is the only way to confirm that a tumor is myeloid sarcoma. During a biopsy, a tissue sample is examined under a microscope. A medical pathologist may also use immunophenotyping to identify specific proteins, called antigens, on the tumor cells. [1]
A bone marrow biopsy may be performed to check for AML alongside myeloid sarcoma. [1]
Test | What it may help evaluate |
CT scan | Tumor location and features that may resemble other masses or abscesses. |
MRI | Soft-tissue detail and the relationship of a tumor to nearby structures. |
PET scan | The location and distribution of active tumor areas. |
Biopsy | Tissue confirmation; this is the only way to confirm myeloid sarcoma. |
Immunophenotyping | Specific antigens on tumor cells. |
Bone marrow biopsy | Whether AML is also present. |
Why is a biopsy important?
Many conditions can look like a tumor on imaging. Benign tumors and abscesses may resemble myeloid sarcoma on CT or MRI. [1]
A biopsy lets the pathology team examine the cells directly. Immunophenotyping adds information about the proteins on those cells. Together with imaging and bone marrow evaluation, these findings help the oncology team determine the diagnosis and plan care. [1]
A biopsy is a medical procedure whose timing, method and risks depend on the tumor’s location and the person’s health. The treating team should explain what to expect.
How is myeloid sarcoma treated?
Myeloid sarcoma treatment depends on the tumor's location and size, its genetic changes, the person's age and health and whether AML or another blood cancer is also present. Possible treatments include:
Chemotherapy: Medicines that kill cancer cells or stop them from multiplying. The medications may be the same as those used for AML. [1]
Radiation therapy: Focused energy beams that destroy cancer cells, sometimes used with chemotherapy. [1]
Targeted therapy: Medicines that attack specific abnormalities in cancer cells. [1]
Allogeneic stem cell transplant: Chemotherapy is used to destroy abnormal stem cells in bone marrow, followed by donated healthy stem cells that can become healthy blood cells. [1]
The treatment plan may combine more than one approach. The oncology team should discuss expected benefits, side effects, interactions, fertility or other life considerations and recovery time.
What does remission mean?
Treatment may put myeloid sarcoma into remission, meaning there is no current evidence of active disease at the level being assessed. Remission does not always mean the disease can never return. [1]
Myeloid sarcoma often comes back. The healthcare team will explain symptoms, tests and follow-up appointments that may help identify recurrence. Do not wait for a scheduled visit if new or worsening symptoms concern you; contact the oncology team. [1]
What is the outlook?
Treatments such as chemotherapy and allogeneic stem cell transplant can help people live longer with myeloid sarcoma. One recent analysis of cases found that overall, 39% of people with the disease were alive five years after diagnosis.
This is a population estimate, not an individual prediction. Myeloid sarcoma affects people differently depending on the tumor’s location, genetic findings, AML status, age, health, response to treatment and recurrence pattern. The treating healthcare professional is the best source for personal expectations.
What should you ask the oncology team?
Useful questions for the oncology team about myeloid sarcoma cover the tumor's location and size, biopsy results, whether AML is also present and which treatment options are being considered.
Where is the tumor located, and how large is it?
What did the biopsy and immunophenotyping show?
Do I also have AML or another blood cancer?
Will I need a bone marrow biopsy?
Which genetic changes were found in the tumor cells?
What treatment options are being considered, and why?
Could chemotherapy, radiation, targeted therapy or a stem cell transplant be part of care?
What side effects and recovery time should I expect?
What symptoms should prompt an urgent call?
What follow-up tests will monitor remission or recurrence?
Is a second opinion or clinical trial appropriate for my situation?
Who can help with emotional, practical, financial or caregiver support?
When should you seek medical care?
Contact a healthcare professional for a new unexplained lump, ongoing fatigue, unexplained weight loss, loss of appetite or pain that may be related to pressure on an organ.
If you already have myeloid sarcoma or AML, contact the oncology team about any new or changing symptoms that could signal complications or recurrence. Severe symptoms or sudden neurological changes require urgent medical evaluation. [1]
Situation | Recommended action |
New soft lump in skin or lymph node | Arrange a clinical evaluation. |
Unexplained weight loss or persistent fatigue | Contact a healthcare professional. |
New organ-related pain | Seek medical review, especially if it persists or worsens. |
New neurological symptoms | Seek urgent medical evaluation. |
Symptoms after treatment or during remission | Contact the oncology team promptly. |
Conclusion: Prompt diagnosis creates a clearer path forward
Myeloid sarcoma is a rare tumor made of abnormal immature white blood cells outside the bone marrow. It often occurs with AML but can also develop on its own. Symptoms may include fatigue, unintentional weight loss, loss of appetite, pressure-related pain or soft lumps in the skin or lymph nodes. [1]
Imaging can locate a tumor, but a biopsy is the only way to confirm myeloid sarcoma. Additional pathology, genetic and bone marrow testing helps the oncology team understand the disease and choose treatment. Care may include chemotherapy, radiation therapy, targeted therapy, allogeneic stem cell transplant or a combination. [1]
Remission is possible, but the disease often returns, so follow-up matters. Population survival figures cannot predict a particular person’s experience. Ask the oncology team to explain what the test results, treatment plan and follow-up schedule mean for you. [1]
Frequently Asked Questions
Is myeloid sarcoma a type of leukemia?
Myeloid sarcoma is both a cancerous tumor and a type of blood cancer. It is closely related to AML because both involve the same cancer cell. A person can have myeloid sarcoma with AML or without it.
What was myeloid sarcoma formerly called?
Older names include chloroma, granulocytic sarcoma and extramedullary acute myeloid tumor. The current name is myeloid sarcoma.
Where does myeloid sarcoma occur?
Myeloid sarcoma can develop throughout the body. Commonly described sites include lymph nodes, tissue under the skin and the gastrointestinal tract. Less often, it affects the reproductive system, brain or lungs.
What are the symptoms of myeloid sarcoma?
Possible symptoms include fatigue, unintentional weight loss, loss of appetite, pain where a tumor presses on an organ and soft lumps in the lymph nodes or skin.
Does every lump mean myeloid sarcoma?
No. Many conditions can cause a lump, including benign tumors and abscesses. Imaging cannot confirm the diagnosis. A biopsy is the only way to confirm myeloid sarcoma.
How is myeloid sarcoma diagnosed?
Evaluation may include CT, MRI or PET imaging, biopsy, immunophenotyping and a bone marrow biopsy to check for AML. A biopsy confirms whether the tumor is myeloid sarcoma.
Can myeloid sarcoma occur without AML?
Yes. When it occurs without AML, clinicians call it primary myeloid sarcoma. A bone marrow biopsy may help determine whether AML is also present.
What causes myeloid sarcoma?
A genetic mutation can cause myeloid cells to become immature cancer cells called myeloblasts. Researchers do not know why the mutation occurs or why the tumor forms outside the bone marrow.
What conditions increase risk?
AML, AML in remission, chronic myeloid leukemia, myeloproliferative neoplasms and myelodysplastic syndrome are associated with increased risk.
How is myeloid sarcoma treated?
Treatment may include chemotherapy, radiation therapy, targeted therapy, allogeneic stem cell transplant or a combination. The plan depends on the tumor, genetic findings, AML status, age and health.
Can myeloid sarcoma go into remission?
Yes. Treatment may put it into remission. However, it often returns, so ongoing follow-up and communication with the oncology team are important.
What is the five-year survival rate?
One recent analysis found that 39% of people with myeloid sarcoma were alive five years after diagnosis overall. This is a population estimate, not an individual prediction. A healthcare professional who knows the person’s disease can explain expectations more accurately.
Is myeloid sarcoma life-threatening?
Myeloid sarcoma can be life-threatening without prompt diagnosis and treatment. Early treatment may slow spread, and remission is possible. Outcomes vary widely by disease features and response to treatment.
What does an allogeneic stem cell transplant involve?
Chemotherapy is used to destroy abnormal stem cells in bone marrow, followed by donated healthy stem cells. The donated cells can eventually become healthy blood cells.
What symptoms could mean myeloid sarcoma has returned?
The oncology team will explain which symptoms, examination findings or test changes may signal recurrence. Contact the team about new or changing symptoms rather than waiting for the next scheduled visit.
Related guides
References
Cleveland Clinic. Myeloid Sarcoma. Cleveland Clinic. Last updated May 11, 2026. https://my.clevelandclinic.org/health/diseases/23179-myeloid-sarcoma
Mali B, Mali A, Mali A, et al. Comprehensive analysis of the survival outcomes and causes of death among patients diagnosed with myeloid sarcoma in the United States from 2000 to 2016: a retrospective SEER-based study. Medicine (Baltimore). 2025;104(1):e41112. PMID 40184098. https://doi.org/10.1097/MD.0000000000041112
Padmanabhan DS, Aguilar JJ, Nanja Reddy S, et al. Clinical and molecular characterization of myeloid sarcoma: a systematic review and meta-analysis. Cancers (Basel). 2025;17(24):3975. PMID 41463221. https://doi.org/10.3390/cancers17243975
National Cancer Institute. Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version. National Cancer Institute. Updated May 16, 2025. https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq
National Cancer Institute. Treatment for Cancer. National Cancer Institute. Accessed October 30, 2026. https://www.cancer.gov/about-cancer/treatment
Disclaimer
This article is for general educational purposes and is not a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified healthcare professional with any questions about a medical condition or treatment.
Do not infer a diagnosis from a lump or imaging result, and do not change cancer treatment without the oncology team. Population survival figures do not predict individual outcomes.
Comments